Impairment of baroreflex control of heart rate and structural changes of cardiac ganglia in conscious streptozotocin (STZ)-induced diabetic mice

Autonomic Neuroscience: Basic and Clinical

Volumn 155, Issue 1-2, 2010, Pages 39-48

  Lin, Min ^a   Ai, Jing ^a,b   Harden, Scott W ^a   Huang, Chenghui ^a   Li, Lihua ^a   Wurster, Robert D ^c  

^a Jack)   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Baroreflex; Cardiac ganglia; Diabetes; Heart; Nucleus ambiguus; Vagal efferent

Indexed keywords

NITROPRUSSIDE SODIUM; PHENYLEPHRINE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CELL LABELING; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONSCIOUSNESS; CONTROLLED STUDY; FEMALE; GANGLION; HEART RATE; HYPERGLYCEMIA; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PERIKARYON; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REFLEX DISORDER; STEADY STATE; STREPTOZOCIN DIABETES; STRUCTURE ANALYSIS; TACHYCARDIA;

ANIMALS; BAROREFLEX; BRADYCARDIA; CONSCIOUSNESS; DIABETES MELLITUS, EXPERIMENTAL; GANGLIA, AUTONOMIC; HEART; HEART RATE; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEURONS, EFFERENT; STREPTOZOCIN;

EID: 77952547088     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.01.004     Document Type: Article

References (52)

1. Ai J., Epstein P.N., Gozal D., Yang B., Wurster R.D., and Cheng Z.J. Morphology and topography of nucleus ambiguus projections to cardiac ganglia in rats and mice. Neuroscience 149 (2007) 845-860
2. Armenia S.M.A., Abdullah N.A., Khan M.A., and Johns E.J. Alpha1A- and alpha1D-adrenoceptors are the major functional subtypes of renal alpha1-adrenoceptors in streptozotocin-induced diabetic and normal Sprague-Dawley rats. Auton. Autacoid Pharmacol. 28 (2008) 1-10
3. Armour J.A. Potential clinical relevance of the "little brain" on the heart. Exp. Physiol. 93 (2007) 165-176
4. Bunag R.D., Tomita T., and Sasaki S. Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness. Hypertension 4 (1982) 556-565
5. Chapleau M.W., and Abboud F.M. The baroreceptor reflex: novel methods and mechanisms. In: Dun N.J., Machado B.H., and Pilowsky P.M. (Eds). Neural Mechanisms of Cardiovascular Regulation (2004), Kluwer Academic, Norwell 1-20
6. Chapleau M.W., Li Z., Meyrelles S.S., Ma X., and Abboud F.M. Mechanisms determining sensitivity of baroreceptors afferents in health and disease. Ann. N.Y. Acad. Sci. 940 (2001) 1-19
7. Cheng Z., and Powley T.L. Nucleus ambiguus projections to cardiac ganglia of rat atria: an anterograde tracing study. J. Comp. Neurol. 424 (2000) 588-606
8. Cheng Z., Powley T.L., Schwaber J.S., and Doyle III F.J. Vagal afferent innervation of the atria of the rat heart reconstructed with confocal microscopy. J. Comp. Neurol. 381 (1997) 1-17
9. Cheng Z., Zhang H., Guo S.Z., Wurster R., and Gozal D. Differential control over postganglionic neurons in rat cardiac ganglia by NA and DmnX neurons: anatomical evidence. Am. J. Physiol., Regul. Integr. Comp. Physiol. 286 (2004) R625-R633
10. Cheng Z., Zhang H., Yu J., Wurster R.H., and Gozal D. Attenuation of baroreflex sensitivity following domoic acid lesion of the nucleus ambiguus of rats. J. Appl. Physiol. 96 (2004) 1137-1145
11. Dall'ago P., D'Agord Schaan B., da Silva V.O., Werner J., da Silva Soares P.P., De Angelis K., and Irigoyen M.C. Parasympathetic dysfunction is associated with baroreflex and chemoreflex impairment in streptozotocin-induced diabetes in rats. Auton. Neurosci. 131 (2007) 28-35
12. De Angelis K., Schaan B.D., Maeda C.Y., Dall'Ago P., Wichi R.B., and Irigoyen M.C. Cardiovascular control in experimental diabetes. Braz. J. Med. Biol. Res. 35 (2002) 1091-1100
13. do Carmo J.M., Huber D.A., Castania J.A., Fazan V.P., Fazan Jr. R., and Salgado H.C. Aortic depressor nerve function examined in diabetic rats by means of two different approaches. J. Neurosci. Meth 161 (2007) 17-22
14. El-Menyar A.A. Dysrhythmia and electrocardiographic changes in diabetes mellitus: pathophysiology and impact on the incidence of sudden cardiac death. J. Cardiovasc. Med. (Hagerstown) 7 (2006) 580-855
15. Epstein P.N., Overbeek P.A., and Means A.R. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58 (1989) 1067-1073
16. Epstein P.N., Ribar T.J., Decker G.L., Yaney G., and Means A.R. Elevated beta-cell calmodulin produces a unique insulin secretory defect in transgenic mice. Endocrinology 130 (1992) 1387-1393
17. Fazan V.P., Salgado H.C., and Barreira A.A. Aortic depressor nerve myelinated fibers in acute and chronic experimental diabetes. Am. J. Hypertens. 19 (2006) 153-160
18. Gouty S., Regalia J., and Helke C.J. Attenuation of the afferent limb of the baroreceptor reflex in streptozotocin-induced diabetic rats. Auton. Neurosci. 89 (2001) 86-95
19. Gross V., Tank J., Partke H.J., Plehm R., Diedrich A., da Costa Goncalves A.C., Luft F.C., and Jordan J. Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice. Auton. Neurosci. 138 (2008) 108-113
20. Gu H., Epstein P.N., Wurster R.D., and Cheng Z.J. Functional changes in baroreceptor afferent, central and efferent components of the baroreflex circuitry in type 1 diabetic mice (OVE26). Neuroscience 152 (2008) 741-752
21. Gu H., Zhang Z.H., Epstein P.N., Li L., Harden S.W., Wurster R.D., and Cheng Z.J. Impaired baroreflex control of renal sympathetic nerve activity in type 1 diabetic mice (OVE26). Neuroscience 161 (2009) 78-85
22. Henneman E., Somjen G., and Carpenter D.O. Functional significance of cell size in spinal motoneurons. J. Neurophysiol. 28 (1965) 560-580
23. Henneman E., Somjen G., and Carpenter D.O. Excitability and inhibitability of motoneurons of different sizes. J. Neurophysiol. 28 (1965) 599-620
24. Huang W.C., Fang T.C., and Cheng J.T. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension 32 (1998) 249-254
25. Inada A., Kanamori H., Arai H., Akashi T., Araki M., Weir G.C., and Fukatsu A. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J. Cell. Physiol. 215 (2008) 383-391
26. Irlbeck M., and Zimmer H.G. Functional responses of the left and right heart of diabetic rats to alpha- and beta-adrenergic receptor stimulation. Diabetes Res. Clin. Pract. 31 (1996) S79-S86 Suppl
27. Kamal A.A., Tay S.S., and Wong W.C. The cardiac ganglia in streptozotocin-induced diabetic rats. Arch. Histol. Cytol. 54 (1991) 41-49
28. Kusaka M., Kishi K., and Sokabe H. Does so-called streptozocin hypertension exist in rats?. Hypertension 10 (1987) 517-521
29. Lawrence I.G., Weston P.J., Bennett M.A., McNally P.G., Burden A.C., and Thurston H. Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus?. Diabet. Med. 14 (1997) 82-85
30. Li, L., Huang, C.H., Ai, J., Yan, B., Gu, H., Ma, Z., Li, A.Y., Shang, X.Y., Harden, S.W., Hatcher, J.T., Wurster, R.D., Cheng, Z.J., in press. Structural remodeling of vagal afferent innervation of aortic arch and nucleus ambiguus (NA) projections to cardiac ganglia in a transgenic mouse model of type 1 diabetes (OVE 26). Journal of Comparative Neurology. doi:10.1002/cne.22363.
31. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., and Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51 (2002) 174-181
32. Lin M., Harden S.W., Li L., Wurster R.D., and Cheng Z.J. Impairment of baroreflex control of heart rate in conscious transgenic mice of type 1 diabetes (OVE26). Auton. Neurosci. 152 (2009) 67-74
33. Loewy A.D., and Spyer K.M. Vagal preganglionic neurons. In: Loewy A.D., and Spyer K.M. (Eds). Central regulation of autonomic functions (1990), Oxford University Press, New York 68-87
34. Lund D.D., Subieta A.R., Pardini B.J., and Chang K.S. Alterations in cardiac parasympathetic indices in STZ-induced diabetic rats. Diabetes 41 (1992) 160-166
35. Maeda C.Y., Fernandes T.G., Lulhier F., and Irigoyen M.C. Streptozotocin diabetes modifies arterial pressure and baroreflex sensitivity in rats. Braz. J. Med. Biol. Res. 28 (1995) 497-501
36. McDowell T.S., Chapleau M.W., Hajduczok G., and Abboud F.M. Baroreflex dysfunction in diabetes mellitus. I. Selective impairment of parasympathetic control of heart rate. Am. J. Physiol. 266 1 Pt 2 (1994) H235-H243
37. McDowell T.S., Hajduczok G., Abboud F.M., and Chapleau M.W. Baroreflex dysfunction in diabetes mellitus. II. Site of baroreflex impairment in diabetic rabbits. Am. J. Physiol. 266 1 Pt 2 (1994) H244-H2449
38. Mendell L.M. The size principle: a rule describing the recruitment of motoneurons. J. Neurophysiol. 93 (2005) 3024-3026
39. Pannirselvam M., Wiehler W.B., Anderson T., and Triggle C.R. Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br. J. Pharmacol. 144 (2005) 953-960
40. Roghani M., and Baluchnejadmojarad T. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul. Pharmacol. 51 (2009) 84-89
41. Ruggeri P., Molinari C., Brunori A., Cogo C.E., Mary D.A., Picchio V., and Vacca G. The direct effect of insulin on barosensitive neurones in the nucleus tractus solitarii of rats. Neuroreport 12 (2001) 3719-3722
42. Salgado H.C., Fazan Jr. R., Fazan V.P., Da Silva V.J., and Barreira A.A. Arterial baroreceptors and experimental diabetes. Ann. N.Y. Acad. Sci 940 (2001) 20-27
43. Schmidt R.E., Dorsey D.A., Beaudet L.N., Frederick K.E., Parvin C.A., Plurad S.B., and Levisetti M.G. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. Am. J. Pathol. 163 (2003) 2077-2091
44. Silan C. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 31 (2008) 897-902
45. Tsujimura T., Nunotani H., Fushimi H., and Inoue T. Morphological changes in autonomic ganglionic cells of the heart in diabetic patients. Diabetes Res. Clin. Pract. 2 (1986) 133-137
46. Vinik A.I., and Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 115 (2007) 387-397
47. Wang S.B., Yang X.Y., Tian S., Yang H.G., and Du G.H. Effect of salvianolic acid A on vascular reactivity of streptozotocin-induced diabetic rats. Life Sci. 85 (2009) 499-504
48. Xue B., Pamidimukkala J., and Hay M. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2177-H2184
49. Yan B., Li L., Harden S.W., Epstein P.N., Wurster R.D., and Cheng Z.J. Diabetes induces neural degeneration in nucleus ambiguus (NA) and attenuates heart rate control in OVE26 mice. Exp. Neurol. 220 (2009) 34-43
50. Ye G., Metreveli N.S., Ren J., and Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52 (2003) 777-783
51. Zheng S., Noonan W.T., Metreveli N.S., Coventry S., Kralik P.M., Carlson E.C., and Epstein P.N. Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 53 (2004) 3248-3257
52. Zheng S., Carlson E.C., Yang L., Kralik P.M., Huang Y., and Epstein P.N. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J. Am. Soc. Nephrol. 19 (2008) 2077-2085